146 related articles for article (PubMed ID: 37922500)
1. Disease spectrum of myopathies with elevated aldolase and normal creatine kinase.
Soontrapa P; Shahar S; Eauchai L; Ernste FC; Liewluck T
Eur J Neurol; 2024 Feb; 31(2):e16117. PubMed ID: 37922500
[TBL] [Abstract][Full Text] [Related]
2. High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology.
Nozaki K; Pestronk A
J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):904-8. PubMed ID: 19240048
[TBL] [Abstract][Full Text] [Related]
3. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
4. [Inflammatory myopathies: diagnosis and classifications].
Dimitri D
Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
[TBL] [Abstract][Full Text] [Related]
5. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic inflammatory myopathies.
Dimachkie MM; Barohn RJ
Semin Neurol; 2012 Jul; 32(3):227-36. PubMed ID: 23117947
[TBL] [Abstract][Full Text] [Related]
7. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
Naim MY; Reed AM
J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Seronegative Inflammatory Myositis to Dermatomyositis With Characteristic Cutaneous Features: A Case Report.
Jevtic D; Dharmah U; Bahar M
J Investig Med High Impact Case Rep; 2023; 11():23247096231217829. PubMed ID: 38097369
[TBL] [Abstract][Full Text] [Related]
9. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
10. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
12. PD-1 Inhibitor-associated Myopathies: Emerging Immune-mediated Myopathies.
Liewluck T; Kao JC; Mauermann ML
J Immunother; 2018 May; 41(4):208-211. PubMed ID: 29200081
[TBL] [Abstract][Full Text] [Related]
13. Myalgia in Patients with Dermatomyositis and Polymyositis Is Attributable to Fasciitis Rather Than Myositis: A Retrospective Study of 32 Patients who Underwent Histopathological Examinations.
Noda K; Yoshida K; Ukichi T; Furuya K; Hirai K; Kingetsu I; Kurosaka D
J Rheumatol; 2017 Apr; 44(4):482-487. PubMed ID: 28148694
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory myopathies: an update for neurologists.
Silva AMS; Campos ED; Zanoteli E
Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):238-248. PubMed ID: 35976321
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of Neuromuscular Disorders With HyperCKemia From a Tertiary Care Pediatric Neuromuscular Center.
Al-Ghamdi F; Darras BT; Ghosh PS
J Child Neurol; 2018 May; 33(6):389-396. PubMed ID: 29577809
[TBL] [Abstract][Full Text] [Related]
16. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy.
Soubrier C; Seguier J; Di Costanzo MP; Ebbo M; Bernit E; Jean E; Veit V; Swiader L; Salort-Campana E; Attarian S; De Paula AM; Kaplanski G; Durand JM; Harlé JR; Schleinitz N
Clin Rheumatol; 2019 Dec; 38(12):3451-3458. PubMed ID: 31440919
[TBL] [Abstract][Full Text] [Related]
17. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathological features of myositis in systemic lupus erythematosus.
Tiniakou E; Goldman D; Corse A; Mammen A; Petri MA
Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35351810
[TBL] [Abstract][Full Text] [Related]
19. [Macrophagic myofasciitis: description and etiopathogenic hypotheses. Study and Research Group on Acquired and Dysimmunity-related Muscular Diseases (GERMMAD) of the French Association against Myopathies (AFM)].
Chérin P; Laforet P; Ghérardi RK; Authier FJ; Coquet M; Maisonobe T; Mussini JM; Pellissier JF; Herson S
Rev Med Interne; 1999 Jun; 20(6):483-9. PubMed ID: 10422140
[TBL] [Abstract][Full Text] [Related]
20. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.
Mozaffar T; Pestronk A
J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):472-8. PubMed ID: 10727483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
